CHASX
Price
$14.36
Change
-$0.38 (-2.58%)
Updated
Feb 21 closing price
Net Assets
91.32M
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

CHASX vs GFACX

Header iconCHASX vs GFACX Comparison
Open Charts CHASX vs GFACXBanner chart's image
Chase Growth N
Price$14.36
Change-$0.38 (-2.58%)
VolumeN/A
Net Assets91.32M
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
CHASX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CHASX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHASX is a StrongBuy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. CHASX (91.3M). CHASX (0.00) and GFACX (0.00) have matching dividends . CHASX was incepted earlier than GFACX: CHASX (27 years) vs GFACX (24 years). CHASX is a more actively managed with annual turnover of: 121.88 vs. GFACX (31.00). GFACX has a lower initial minimum investment than CHASX: GFACX (250) vs CHASX (2000). GFACX annual gain was more profitable for investors over the last year : 10.15 vs. CHASX (2.87). GFACX return over 5 years is better than : 32.83 vs. CHASX (11.93).
CHASXGFACXCHASX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years24 years-
Gain YTD0.4902.98016%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets91.3M304B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year2.8710.1528%
Returns for 3 years16.7517.6995%
Returns for 5 years11.9332.8336%
Returns for 10 years4.2155.638%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding